Cited by 691

The DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Open access

Perk, Joep, De Backer, Guy, Gohlke, Helmut, Graham, Ian, Reiner, Željko, Verschuren, W.M. Monique, Albus, Christian, Benlian, Pascale, Boysen, Gudrun, Cifkova, Renata, Deaton, Christi, Ebrahim, Shah, Fisher, Miles, Germano, Giuseppe, Hobbs, Richard, Hoes, Arno, Karadeniz, Sehnaz, Mezzani, Alessandro, Prescott, Eva, Ryden, Lars, Scherer, Martin, Syvänne, Mikko, Scholte Op Reimer, Wilma J.M., Vrints, Christiaan, Wood, David, Zamorano, Jose Luis, Zannad, Faiez·2012·Atherosclerosis

DOI 10.1016/j.atherosclerosis.2012.05.007

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2012.05.007

Cites

273 of 273 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Adherence to medication.
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117

Show all 273 references

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
External validation of multivariable prediction models: a systematic review of methodological conduct and reporting
Collins, G. S., de Groot, J. A., Dutton, S., Omar, O., Shanyinde, M., Tajar, A., Voysey, M., Wharton, R., Yu, L.-M., Moons, K. G., et al. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-40 · Cited by 729
Risk stratification for sudden cardiac death: Current status and challenges for the future
Wellens, H. J. J., Schwartz, P. J., Lindemans, F. W., Buxton, A. E., Goldberger, J. J., Hohnloser, S. H., Huikuri, H. V., Kaab, S., La Rovere, M. T., Malik, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu176 · Cited by 405
Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 Persons
Fischer, K., Kettunen, J., Würtz, P., Haller, T., Havulinna, A. S., Kangas, A. J., Soininen, P., Esko, T., Tammesoo, M.-L., Mägi, R., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001606 · Cited by 344
Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology
Pogosova, N., Saner, H., Pedersen, S. S., Cupples, M. E., McGee, H., Höfer, S., Doyle, F., Schmid, J.-P., von Känel, R., & on behalf of the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487314543075 · Cited by 292
Personality traits as risk factors for stroke and coronary heart disease mortality: pooled analysis of three cohort studies
Jokela, M., Pulkki-Råback, L., Elovainio, M., & Kivimäki, M. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9548-z · Cited by 269
Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men
Gliemann, L., Schmidt, J. F., Olesen, J., Biensø, R. S., Peronard, S. L., Grandjean, S. U., Mortensen, S. P., Nyberg, M., Bangsbo, J., Pilegaard, H., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.258061 · Cited by 244
Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018
Fanaroff, A. C., Califf, R. M., Windecker, S., Smith, S. C., & Lopes, R. D. (2019) · JAMA · doi:10.1001/jama.2019.1122 · Cited by 228
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
Banach, M., Stulc, T., Dent, R., & Toth, P. P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.075 · Cited by 197
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Moriarty, P. M., Jacobson, T. A., Bruckert, E., Thompson, P. D., Guyton, J. R., Baccara-Dinet, M. T., & Gipe, D. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.09.007 · Cited by 154
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Saraiva, F. K., & Sposito, A. C. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0142-7 · Cited by 143
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
On behalf of the EUROASPIRE Investigators, Gyberg, V., De Bacquer, D., De Backer, G., Jennings, C., Kotseva, K., Mellbin, L., Schnell, O., Tuomilehto, J., Wood, D., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0296-y · Cited by 140
Self-citation
Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ghaedi, E., Mohammadi, M., Mohammadi, H., Ramezani-Jolfaie, N., Malekzadeh, J., Hosseinzadeh, M., & Salehi-Abargouei, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz007 · Cited by 94
PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016
Banach, M., Jankowski, P., Jóźwiak, J., Cybulska, B., Windak, A., Guzik, T., Mamcarz, A., Broncel, M., & Tomasik, T. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.64712 · Cited by 86
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
EUROASPIRE IV & V Investigators, Ferrannini, G., De Bacquer, D., Vynckier, P., De Backer, G., Gyberg, V., Kotseva, K., Mellbin, L., Norhammar, A., Tuomilehto, J., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01233-6 · Cited by 54
Self-citation
Low-fat and high-fat dairy products are differently related to blood lipids and cardiovascular risk score
Kai, S. H. Y., Bongard, V., Simon, C., Ruidavets, J.-B., Arveiler, D., Dallongeville, J., Wagner, A., Amouyel, P., & Ferrières, J. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487313503283 · Cited by 61
Ageing modifies the effects of beetroot juice supplementation on 24-hour blood pressure variability: An individual participant meta-analysis
Siervo, M., Lara, J., Jajja, A., Sutyarjoko, A., Ashor, A. W., Brandt, K., Qadir, O., Mathers, J. C., Benjamin, N., Winyard, P. G., et al. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.04.007 · Cited by 52
Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction
Rezeli, M., Végvári, Á., Donnarumma, F., Gidlöf, O., Smith, J. G., Erlinge, D., & Marko-Varga, G. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.05.016 · Cited by 33
Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: a nationwide survey of 2674 individuals in Hungary
Mark, L., Vallejo-Vaz, A. J., Reiber, I., Paragh, G., Kondapally Seshasai, S. R., & Ray, K. K. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.810 · Cited by 30
Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients
Barreto Silva, M. I., Lemos, C. C. D. S., Torres, M. R. S. G., & Bregman, R. (2014) · Nutrition · doi:10.1016/j.nut.2013.08.004 · Cited by 27
Impact of early evidence of atherosclerotic changes on early treatment in children with familial hypercholesterolemia
Reiner, Ž. (2014) · Circulation Research · doi:10.1161/circresaha.113.302952 · Cited by 26
Self-citation
Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004–2014
Langsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.025 · Cited by 21
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance
Cacciatori, V., Zoppini, G., Bellavere, F., Rigolon, R., Thomaseth, K., Pichiri, I., Trombetta, M., Dauriz, M., De Santi, F., Targher, G., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00300 · Cited by 18
Prediction of Ankle Brachial Index with Photoplethysmography Using Convolutional Long Short Term Memory
Lee, J. J., Heo, J. H., Han, J. H., Kim, B. R., Gwon, H. Y., & Yoon, Y. R. (2020) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-020-00507-w · Cited by 11

Authors: Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., Deaton, C., Ebrahim, S., Fisher, M., Germano, G., Hobbs, R., Hoes, A., Karadeniz, S., Mezzani, A., Prescott, E., Ryden, L., Scherer, M., Syvänne, M., Scholte Op Reimer, W. J. M., Vrints, C., Wood, D., Zamorano, J. L., & Zannad, F.
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 2012-07
Volume: 223
Issue: 1
Pages: 1-68
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/j.atherosclerosis.2012.05.007
OpenAlex: W3150330975
Cited by: 691
References: 273
FWCI: 101.57
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources